BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24160322)

  • 1. Sparing of the dystrophin-deficient cranial sartorius muscle is associated with classical and novel hypertrophy pathways in GRMD dogs.
    Nghiem PP; Hoffman EP; Mittal P; Brown KJ; Schatzberg SJ; Ghimbovschi S; Wang Z; Kornegay JN
    Am J Pathol; 2013 Nov; 183(5):1411-24. PubMed ID: 24160322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.
    Kornegay JN; Bogan DJ; Bogan JR; Dow JL; Wang J; Fan Z; Liu N; Warsing LC; Grange RW; Ahn M; Balog-Alvarez CJ; Cotten SW; Willis MS; Brinkmeyer-Langford C; Zhu H; Palandra J; Morris CA; Styner MA; Wagner KR
    Skelet Muscle; 2016; 6():14. PubMed ID: 27047655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired autophagy correlates with golden retriever muscular dystrophy phenotype.
    Stoughton WB; Li J; Balog-Alvarez C; Kornegay JN
    Muscle Nerve; 2018 Sep; 58(3):418-426. PubMed ID: 29513363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle lesions associated with dystrophin deficiency in neonatal golden retriever puppies.
    Nguyen F; Cherel Y; Guigand L; Goubault-Leroux I; Wyers M
    J Comp Pathol; 2002; 126(2-3):100-8. PubMed ID: 11944998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.
    Robriquet F; Babarit C; Larcher T; Dubreil L; Ledevin M; Goubin H; Rouger K; Guével L
    BMC Musculoskelet Disord; 2016 May; 17():209. PubMed ID: 27170302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs.
    Araujo KP; Bonuccelli G; Duarte CN; Gaiad TP; Moreira DF; Feder D; Belizario JE; Miglino MA; Lisanti MP; Ambrosio CE
    PLoS One; 2013; 8(4):e61367. PubMed ID: 23579193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvessel density in muscles of dogs with golden retriever muscular dystrophy.
    Nguyen F; Guigand L; Goubault-Leroux I; Wyers M; Cherel Y
    Neuromuscul Disord; 2005 Feb; 15(2):154-63. PubMed ID: 15694137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy.
    Bish LT; Sleeper MM; Forbes SC; Morine KJ; Reynolds C; Singletary GE; Trafny D; Pham J; Bogan J; Kornegay JN; Vandenborne K; Walter GA; Sweeney HL
    Hum Gene Ther; 2011 Dec; 22(12):1499-509. PubMed ID: 21787232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cranial sartorius muscle undergoes true hypertrophy in dogs with golden retriever muscular dystrophy.
    Kornegay JN; Cundiff DD; Bogan DJ; Bogan JR; Okamura CS
    Neuromuscul Disord; 2003 Aug; 13(6):493-500. PubMed ID: 12899877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength.
    Martin PT; Zygmunt DA; Ashbrook A; Hamilton S; Packer D; Birch SM; Bettis AK; Balog-Alvarez CJ; Guo LJ; Nghiem PP; Kornegay JN
    PLoS One; 2021; 16(3):e0248721. PubMed ID: 33770101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms.
    Alexander MS; Casar JC; Motohashi N; Vieira NM; Eisenberg I; Marshall JL; Gasperini MJ; Lek A; Myers JA; Estrella EA; Kang PB; Shapiro F; Rahimov F; Kawahara G; Widrick JJ; Kunkel LM
    J Clin Invest; 2014 Jun; 124(6):2651-67. PubMed ID: 24789910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skinned single fibers from normal and dystrophin-deficient dogs incur comparable stretch-induced force deficits.
    Childers MK; Staley JT; Kornegay JN; McDonald KS
    Muscle Nerve; 2005 Jun; 31(6):768-71. PubMed ID: 15736272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic myostatin decrease in the golden retriever muscular dystrophy model does not significantly affect the ubiquitin proteasome system despite enhancing the severity of disease.
    Cotten SW; Kornegay JN; Bogan DJ; Wadosky KM; Patterson C; Willis MS
    Am J Transl Res; 2013; 6(1):43-53. PubMed ID: 24349620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle.
    Martin PT; Golden B; Okerblom J; Camboni M; Chandrasekharan K; Xu R; Varki A; Flanigan KM; Kornegay JN
    PLoS One; 2014; 9(2):e88226. PubMed ID: 24505439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping.
    Vulin A; Barthélémy I; Goyenvalle A; Thibaud JL; Beley C; Griffith G; Benchaouir R; le Hir M; Unterfinger Y; Lorain S; Dreyfus P; Voit T; Carlier P; Blot S; Garcia L
    Mol Ther; 2012 Nov; 20(11):2120-33. PubMed ID: 22968479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog.
    Zucconi E; Valadares MC; Vieira NM; Bueno CR; Secco M; Jazedje T; da Silva HC; Vainzof M; Zatz M
    Neuromuscul Disord; 2010 Jan; 20(1):64-70. PubMed ID: 19944604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin.
    Porter JD; Rafael JA; Ragusa RJ; Brueckner JK; Trickett JI; Davies KE
    J Cell Sci; 1998 Jul; 111 ( Pt 13)():1801-11. PubMed ID: 9625743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN contributes to profound PI3K/Akt signaling pathway deregulation in dystrophin-deficient dog muscle.
    Feron M; Guevel L; Rouger K; Dubreil L; Arnaud MC; Ledevin M; Megeney LA; Cherel Y; Sakanyan V
    Am J Pathol; 2009 Apr; 174(4):1459-70. PubMed ID: 19264909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A normal life without muscle dystrophin.
    Zatz M; Vieira NM; Zucconi E; Pelatti M; Gomes J; Vainzof M; Martins-Bach AB; Garcia Otaduy MC; Bento dos Santos G; Amaro E; Landini V; Andrade T
    Neuromuscul Disord; 2015 May; 25(5):371-4. PubMed ID: 25770920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.